
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9957732
[patent_doc_number] => 09005935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Methods and compositions for DNA fragmentation and tagging by transposases'
[patent_app_type] => utility
[patent_app_number] => 13/470087
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 9954
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470087
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470087 | Methods and compositions for DNA fragmentation and tagging by transposases | May 10, 2012 | Issued |
Array
(
[id] => 9635669
[patent_doc_number] => 20140213779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'RIBOSWITCHES'
[patent_app_type] => utility
[patent_app_number] => 14/116727
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 25135
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116727
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116727 | RIBOSWITCHES | May 9, 2012 | Abandoned |
Array
(
[id] => 9922620
[patent_doc_number] => 08980579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Chromosomal landing pads and related uses'
[patent_app_type] => utility
[patent_app_number] => 13/440661
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14316
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440661 | Chromosomal landing pads and related uses | Apr 4, 2012 | Issued |
Array
(
[id] => 13237423
[patent_doc_number] => 10131903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Microfluidic platform for synthetic biology applications
[patent_app_type] => utility
[patent_app_number] => 13/437727
[patent_app_country] => US
[patent_app_date] => 2012-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 89
[patent_no_of_words] => 15907
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13437727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/437727 | Microfluidic platform for synthetic biology applications | Apr 1, 2012 | Issued |
Array
(
[id] => 10039478
[patent_doc_number] => 09080177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'pAVEC'
[patent_app_type] => utility
[patent_app_number] => 14/110217
[patent_app_country] => US
[patent_app_date] => 2012-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9392
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110217
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110217 | pAVEC | Apr 1, 2012 | Issued |
Array
(
[id] => 9294589
[patent_doc_number] => 20140038223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'CRK-A NOVEL TARGET FOR CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/008032
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6574
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008032
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008032 | CRK-A NOVEL TARGET FOR CANCER THERAPY | Mar 29, 2012 | Abandoned |
Array
(
[id] => 10019854
[patent_doc_number] => 09062326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Expression vector for animal cells'
[patent_app_type] => utility
[patent_app_number] => 14/008286
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 11133
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008286 | Expression vector for animal cells | Mar 29, 2012 | Issued |
Array
(
[id] => 9306588
[patent_doc_number] => 20140045262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'CONSTRUCTS AND METHOD FOR REGULATING GENE EXPRESSION OR FOR DETECTING AND CONTROLLING A DNA LOCUS IN EUKARYOTES'
[patent_app_type] => utility
[patent_app_number] => 14/006743
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14586
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006743
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/006743 | Constructs and method for regulating gene expression or for detecting and controlling a DNA locus in eukaryotes | Mar 22, 2012 | Issued |
Array
(
[id] => 9294600
[patent_doc_number] => 20140038234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Expression System With Sar Element From IFNalpha2'
[patent_app_type] => utility
[patent_app_number] => 14/110944
[patent_app_country] => US
[patent_app_date] => 2012-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5259
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110944
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110944 | Expression system with SAR element from IFNα2 | Mar 19, 2012 | Issued |
Array
(
[id] => 11874708
[patent_doc_number] => 09746475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-29
[patent_title] => 'Antibody and antibody mimetic for visualization and ablation of endogenous proteins'
[patent_app_type] => utility
[patent_app_number] => 14/004879
[patent_app_country] => US
[patent_app_date] => 2012-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 20376
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004879
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/004879 | Antibody and antibody mimetic for visualization and ablation of endogenous proteins | Mar 12, 2012 | Issued |
Array
(
[id] => 10142528
[patent_doc_number] => 09175331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Inhibitors of human EZH2, and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/418242
[patent_app_country] => US
[patent_app_date] => 2012-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 51621
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418242
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/418242 | Inhibitors of human EZH2, and methods of use thereof | Mar 11, 2012 | Issued |
Array
(
[id] => 8278362
[patent_doc_number] => 20120172236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'Selection and Enrichment of Proteins Using In Vitro Compartmentalization'
[patent_app_type] => utility
[patent_app_number] => 13/415504
[patent_app_country] => US
[patent_app_date] => 2012-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11088
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415504
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/415504 | Selection and enrichment of proteins using in vitro compartmentalization | Mar 7, 2012 | Issued |
Array
(
[id] => 12254463
[patent_doc_number] => 09926601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer'
[patent_app_type] => utility
[patent_app_number] => 14/000995
[patent_app_country] => US
[patent_app_date] => 2012-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 35103
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000995
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000995 | Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer | Feb 23, 2012 | Issued |
Array
(
[id] => 9306502
[patent_doc_number] => 20140045176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'METHOD FOR CONCENTRATING CELLS THAT ARE GENETICALLY ALTERED BY NUCLEASES'
[patent_app_type] => utility
[patent_app_number] => 14/000920
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 16366
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000920 | Method for concentrating cells that are genetically altered by nucleases | Feb 21, 2012 | Issued |
Array
(
[id] => 9212524
[patent_doc_number] => 20140011701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Prognostic Marker Sets For Prostate Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/004507
[patent_app_country] => US
[patent_app_date] => 2012-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5049
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004507
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/004507 | Prognostic Marker Sets For Prostate Cancer | Feb 15, 2012 | Abandoned |
Array
(
[id] => 8394123
[patent_doc_number] => 20120231965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'DRUG SELECTION FOR COLORECTAL CANCER THERAPY USING ANTIBODY-BASED ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 13/365638
[patent_app_country] => US
[patent_app_date] => 2012-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 30841
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13365638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/365638 | DRUG SELECTION FOR COLORECTAL CANCER THERAPY USING ANTIBODY-BASED ARRAYS | Feb 2, 2012 | Abandoned |
Array
(
[id] => 9134863
[patent_doc_number] => 20130295578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'METHODS FOR SCREENING FOR DRUG RESISTANCE IN CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/978724
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6644
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978724
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978724 | METHODS FOR SCREENING FOR DRUG RESISTANCE IN CANCER TREATMENT | Jan 9, 2012 | Abandoned |
Array
(
[id] => 9850063
[patent_doc_number] => 08951790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => 'Mammalian expression vector pUHAB'
[patent_app_type] => utility
[patent_app_number] => 13/344905
[patent_app_country] => US
[patent_app_date] => 2012-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 4
[patent_no_of_words] => 6309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13344905
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/344905 | Mammalian expression vector pUHAB | Jan 5, 2012 | Issued |
Array
(
[id] => 9269636
[patent_doc_number] => 20140024554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'COMPLEX SETS OF MIRNAS AS NON-INVASIVE BIOMARKERS FOR GLIOBLASTOMA'
[patent_app_type] => utility
[patent_app_number] => 13/995956
[patent_app_country] => US
[patent_app_date] => 2011-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 23115
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995956
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/995956 | COMPLEX SETS OF MIRNAS AS NON-INVASIVE BIOMARKERS FOR GLIOBLASTOMA | Dec 27, 2011 | Abandoned |
Array
(
[id] => 9120891
[patent_doc_number] => 20130287814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'DNA Expression Construct'
[patent_app_type] => utility
[patent_app_number] => 13/996829
[patent_app_country] => US
[patent_app_date] => 2011-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4725
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996829
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996829 | DNA Expression Construct | Dec 22, 2011 | Abandoned |